This site looks better in landscape mode! Turn your device on its side!
Skip to content
AKLRD develops novel solutions for inflammatory diseases with a high unmet need
Over half of people diagnosed with knee osteoarthritis are under 65 years of age
APPA reduces senescence & reactive oxygen species production
New studies suggests APPA protects against joint damage
APPA Phase II human study completes ahead of schedule